Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cofilin siRNA, a promising therapy for treatment of hemorrhagic stroke

Feb. 15, 2022

New complement C1s subcomponent inhibitors discovered at Annexon

Feb. 15, 2022

STC-2 administration confers post-stroke functional recovery in a preclinical model

Feb. 14, 2022

Targeting sphingolipid synthesis has multiple beneficial effects in Duchenne model

Feb. 14, 2022

Roche patents vasopressin V1A receptor antagonists

Feb. 14, 2022

NOS targeting to treat ischemic stroke

Feb. 14, 2022

Regulating ANXA1 activity is an approach for treating sickle cell disease-associated stroke

Feb. 11, 2022

Targeting TRPM2 using tat-M2NX improves functional outcome following MCAO

Feb. 11, 2022

Researchers unveil therapeutic targets in ischemic stroke

Feb. 11, 2022

Virpax reports preclinical findings on Envelta for acute and chronic pain

Feb. 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...